Long-acting CAB/RPV in people with suboptimal adherence: IMPALA study results at 48 weeks
17 July 2025. Related: Early access, Conference reports, Antiretrovirals, Drug resistance.
17 July 2025. Related: Early access, Conference reports, Antiretrovirals, Drug resistance.
17 July 2025. Related: Early access, Conference reports, Treatment strategies.
16 July 2025. Related: Early access, Conference reports, Treatment strategies.
16 July 2025. Related: Early access, Conference reports, Treatment strategies.
16 July 2025. Related: Early access, Treatment access.
15 July 2025. Related: Early access, Conference reports, Treatment access, Activism & advocacy.
13 July 2025. Related: Early access, Conference reports, Activism & advocacy.
12 July 2025. Related: Early access, Conference reports.
9 July 2025. Related: Early access, Treatment access, HIV prevention and transmission.
8 July 2025. Related: In memory, Early access, Special reports.